June 24, 2020 / 5:17 AM / 18 days ago

BRIEF-Targovax: Presentation Of Pre-Clinical Data From Next Generation ONCOS At AACR Virtual Annual Conference

June 24 (Reuters) - Targovax ASA:

* TARGOVAX ANNOUNCES PRESENTATION OF PRE-CLINICAL DATA FROM NEXT GENERATION ONCOS AT AACR VIRTUAL ANNUAL CONFERENCE

* PRE-CLINICAL IN VITRO AND IN VIVO FINDINGS DEMONSTRATED THAT BOTH ONCOS-210 & ONCOS-212 HAVE ANTI-CANCER PROPERTIES AND THAT DOUBLE TRANSGENES ACT SYNERGISTICALLY Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below